WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018013771) TREATMENT OF PAIN USING HYDROCODONE FORMULATIONS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2018/013771    International Application No.:    PCT/US2017/041869
Publication Date: 18.01.2018 International Filing Date: 13.07.2017
IPC:
A61K 31/485 (2006.01), A61K 9/20 (2006.01), A61K 9/50 (2006.01), A61P 25/04 (2006.01)
Applicants: CIMA LABS INC. [US/US]; 7325 Aspen Lane Brooklyn Park, MN 55428 (US)
Inventors: HABIB, Walid, A.; (US).
HAMED, Ehab; (US).
VEGA ZEPEDA, Manuel, A.; (US).
SEBURG, Randal, A.; (US)
Agent: VALLA, S., Maurice; (US).
LODISE, Stephanie, A.; (US).
HOFFMAN, David, B.; (US)
Priority Data:
62/362,017 13.07.2016 US
Title (EN) TREATMENT OF PAIN USING HYDROCODONE FORMULATIONS
(FR) TRAITEMENT DE LA DOULEUR AU MOYEN DE FORMULATIONS D’HYDROCODONE
Abstract: front page image
(EN)Extended release, abuse deterrent dosage forms in which the active ingredient consists essentially of hydrocodone are disclosed, wherein administration of the dosage form to a subject in at least one dose per day over multiple days does not produce a therapeutically significant effect on one or more pharmacokinetic parameters following a first dose or at steady state. Methods of treating pain using such dosage forms are also provided.
(FR)La présente invention concerne des formes pharmaceutiques inviolables à libération prolongée dans lesquelles la substance active est essentiellement constituée d’hydrocodone, l’administration de la forme pharmaceutique à un sujet à au moins une dose par jour sur plusieurs jours ne produisant pas un effet thérapeutiquement significatif sur un ou plusieurs paramètres pharmacocinétiques après une première dose ou à l’état stationnaire. L’invention concerne en outre des procédés de traitement de la douleur au moyen de telles formes pharmaceutiques.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)